This is cash held in Argentina on behalf of a State Owned Enterprise customer in Venezuela (PDVSA). It is not cash Fluence can access until they deliver sales and can have funds released to them. So while the cash is set aside in a separate country to Venezuela (because VZ is a political shitstorm of instability right now), it's not in an FLC bank account as yet. Think of it as a pre-payment in to a third party bank account for safekeeping in the period before FLC actually deliver their projects.
Their comment in the 4C that on a like for like basis the actual available cash holding is $33m is quite annoying. It basically says you can't rely on the figure at the bottom of the cashflow statement as being a reliable indicator of the actual available cash balance. This will catch out plenty of people who skim read the 4C to work out the cash balance I would imagine.
- Forums
- ASX - By Stock
- FLC
- Ann: Appendix 4C - quarterly Q4 and Commentary
FLC
fluence corporation limited
Add to My Watchlist
1.28%
!
4.0¢

Ann: Appendix 4C - quarterly Q4 and Commentary, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.0¢ |
Change
0.001(1.28%) |
Mkt cap ! $42.87M |
Open | High | Low | Value | Volume |
3.8¢ | 4.0¢ | 3.8¢ | $6.935K | 177.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 25733 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 320071 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25733 | 0.039 |
2 | 33499 | 0.038 |
3 | 269203 | 0.037 |
1 | 333000 | 0.036 |
1 | 200000 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 320071 | 2 |
0.041 | 34644 | 2 |
0.042 | 147100 | 3 |
0.043 | 120000 | 1 |
0.047 | 2224 | 1 |
Last trade - 15.42pm 04/07/2025 (20 minute delay) ? |
Featured News
FLC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online